Related Experiment Video
Updated: Sep 17, 2025
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Dysregulated microRNAs in blood correlate with central nervous system neuropathology of prion disease
Sonia Pérez-Lázaro1,2,3, Inmaculada Martín-Burriel4,5,6,7,8, Luca Cozzuto9
1Centro de Encefalopatías y Enfermedades Transmisibles Emergentes (CEETE), Facultad de Veterinaria, Universidad de Zaragoza, Zaragoza, Spain. soniperez97@gmail.com.
Abstract:
The role of microRNAs (miRNAs) in neurodegenerative diseases has gained significant attention because of their involvement in gene regulation and potential as biomarkers. In prion diseases, including scrapie, miRNAs may modulate pathogenesis and disease progression. This study investigated circulating miRNA profiles in the blood of sheep naturally affected by scrapie at preclinical and clinical stages using small RNA sequencing and RT-qPCR validation. While only one novel miRNA was dysregulated in preclinical blood samples, 66 previously annotated miRNAs were significantly dysregulated in clinical sheep compared with healthy sheep. These miRNAs are associated with pathways commonly altered in neurodegenerative diseases, such as autophagy, ubiquitin-mediated proteolysis, and endoplasmic reticulum protein processing. Notably, miR-1271-5p, let-7f-5p, miR-186-5p, and miR-425-5p were consistently upregulated in the central nervous system of clinical animals, replicating the results observed in blood, with an increasing trend already in the preclinical stage and a strong correlation with neuropathological prion features. Additionally, predicted target genes such as UBQLN2, PGK1, KRAS, and CLTC were inversely expressed relative to these miRNAs, supporting their regulatory roles. These findings highlight the relevance of circulating miRNAs in prion neuropathology and support further research into the specific functional roles of these miRNAs and their predictive capacity for disease progression.
Insights
Circulating microRNAs (miRNAs) show promise as biomarkers for prion diseases like scrapie. Dysregulated miRNAs in sheep blood correlate with disease progression and neuropathology, offering insights into disease mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key gene regulators implicated in neurodegenerative diseases.
- Prion diseases, such as scrapie, involve complex pathogenesis where miRNAs may play a role.
- Identifying reliable biomarkers for early disease detection is crucial for neurodegenerative conditions.
Purpose of the Study:
- To investigate circulating miRNA profiles in sheep naturally affected by scrapie.
- To identify specific miRNAs associated with preclinical and clinical stages of scrapie.
- To explore the correlation between miRNA expression, neuropathology, and potential target genes.
Main Methods:
- Small RNA sequencing was employed to profile circulating miRNAs in sheep blood.
- RT-qPCR was used for validation of dysregulated miRNA candidates.
- Bioinformatic analysis predicted target genes and associated pathways.
Main Results:
- 66 annotated miRNAs were significantly dysregulated in clinical scrapie cases compared to healthy controls.
- Specific miRNAs (e.g., miR-1271-5p, let-7f-5p) were upregulated in both blood and CNS, correlating with neuropathology.
- A trend of increasing miRNA levels was observed from preclinical to clinical stages.
- Predicted target genes involved in key cellular processes like autophagy and protein processing showed inverse expression.
Conclusions:
- Circulating miRNAs are relevant biomarkers for prion neuropathology in scrapie.
- Specific miRNAs demonstrate potential for predicting disease progression and severity.
- Further research into the functional roles of these miRNAs could elucidate disease mechanisms.
